Skip to main content

Current considerations for clinical management and care of non-alcoholic fatty liver disease: Insights from the 1st International Workshop of the Canadian NASH Network (CanNASH)

Publication ,  Journal Article
Sebastiani, G; Patel, K; Ratziu, V; Feld, JJ; Neuschwander-Tetri, BA; Pinzani, M; Petta, S; Berzigotti, A; Metrakos, P; Shoukry, N; Brunt, EM ...
Published in: Canadian Liver Journal
January 1, 2022

Non-alcoholic fatty liver disease (NAFLD) affects approximately 8 million Canadians. NAFLD refers to a disease spectrum ranging from bland steatosis to non-alcoholic steatohepatitis (NASH). Nearly 25% of patients with NAFLD develop NASH, which can progress to liver cirrhosis and related end-stage complications. Type 2 diabetes and obesity represent the main risk factors for the disease. The Canadian NASH Network is a national collaborative organization of health care professionals and researchers with a primary interest in enhancing understanding, care, education, and research around NAFLD, with a vision of best practices for this disease state. At the 1st International Workshop of the CanNASH network in April 2021, a joint event with the single topic conference of the Canadian Association for the Study of the Liver (CASL), clinicians, epidemiologists, basic scientists, and community members came together to share their work under the theme of NASH. This symposium also marked the initiation of collaborations between Canadian and other key opinion leaders in the field representative of international liver associations. The main objective is to develop a policy framework that outlines specific targets, suggested activities, and evidence-based best practices to guide provincial, territorial, and federal organizations in developing multidisciplinary models of care and strategies to address this epidemic.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Canadian Liver Journal

DOI

EISSN

2561-4444

Publication Date

January 1, 2022

Volume

5

Issue

1

Start / End Page

61 / 90
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Sebastiani, G., Patel, K., Ratziu, V., Feld, J. J., Neuschwander-Tetri, B. A., Pinzani, M., … Ramji, A. (2022). Current considerations for clinical management and care of non-alcoholic fatty liver disease: Insights from the 1st International Workshop of the Canadian NASH Network (CanNASH). Canadian Liver Journal, 5(1), 61–90. https://doi.org/10.3138/canlivj-2021-0030
Sebastiani, G., K. Patel, V. Ratziu, J. J. Feld, B. A. Neuschwander-Tetri, M. Pinzani, S. Petta, et al. “Current considerations for clinical management and care of non-alcoholic fatty liver disease: Insights from the 1st International Workshop of the Canadian NASH Network (CanNASH).” Canadian Liver Journal 5, no. 1 (January 1, 2022): 61–90. https://doi.org/10.3138/canlivj-2021-0030.
Sebastiani G, Patel K, Ratziu V, Feld JJ, Neuschwander-Tetri BA, Pinzani M, et al. Current considerations for clinical management and care of non-alcoholic fatty liver disease: Insights from the 1st International Workshop of the Canadian NASH Network (CanNASH). Canadian Liver Journal. 2022 Jan 1;5(1):61–90.
Sebastiani, G., et al. “Current considerations for clinical management and care of non-alcoholic fatty liver disease: Insights from the 1st International Workshop of the Canadian NASH Network (CanNASH).” Canadian Liver Journal, vol. 5, no. 1, Jan. 2022, pp. 61–90. Scopus, doi:10.3138/canlivj-2021-0030.
Sebastiani G, Patel K, Ratziu V, Feld JJ, Neuschwander-Tetri BA, Pinzani M, Petta S, Berzigotti A, Metrakos P, Shoukry N, Brunt EM, Tang A, Cobbold JF, Ekoe JM, Seto K, Ghali P, Chevalier S, Anstee QM, Watson H, Bajaj H, Stone J, Swain MG, Ramji A. Current considerations for clinical management and care of non-alcoholic fatty liver disease: Insights from the 1st International Workshop of the Canadian NASH Network (CanNASH). Canadian Liver Journal. 2022 Jan 1;5(1):61–90.

Published In

Canadian Liver Journal

DOI

EISSN

2561-4444

Publication Date

January 1, 2022

Volume

5

Issue

1

Start / End Page

61 / 90